Zhonghong Healthcare (300981.SZ) plans to invest in Southeast Asia SEA3 to expand overseas business space

Zhitong Finance App News, Zhonghong Healthcare (300981.SZ) issued an announcement. In order to implement the company's strategic plan, expand overseas business space, and enhance the company's comprehensive competitive strength, it agreed that the subsidiary Zhonghong International (Hong Kong) Trading Co., Ltd. (hereinafter referred to as “Zhonghong Hong Kong”, the company's wholly-owned subsidiary) and Guilin Hengbao Protection International Co., Ltd. (hereinafter referred to as “Hengbao International”), a holding subsidiary holding 70% of the company's shares, signed a share sale agreement and shareholder agreement with a total cash of RMB 6.97 yuan acquisitions Southeast Asia SEA3 (hereinafter referred to as the “Target Company”) has a total share of 75%, and agreed that after the share transfer, Zhonghong Hong Kong and Hengbao International (Guilin Hengbao Health Protection Co., Ltd. initially increased their capital by RMB 10 million) to SEA3 with their own capital by RMB 52.975,500 and RMB 22.7038 million respectively, for a total capital increase of RMB 756.794 million.

SEA3, the target company of this transaction, is mainly engaged in the production and sale of medical grade gloves. The target company has EU ISO13485 quality management system certification, EU CE certification, and US FDA 510 (k) certification, etc., and has perfect export qualifications to Europe and the US.

After the transaction is completed, the company and SEA3 can achieve complementary advantages in supply chain resources, domestic and foreign channels, management and operation, technology research and development, and high-end talents to give full play to the advantages of resource integration.